Healthcare 21 (HC21) are delighted to announce that we have signed this week a new sales, marketing and distribution agreement with Acelity, a global wound care and regenerative medicine company, for their surgical portfolio covering the German, Austrian and Luxembourg markets.
Available in more than 80 countries, the innovative and complementary ACELITY product portfolio delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. HC 21 already have an excellent working relationship successfully promoting much of their world class portfolio of regenerative wound management products across the UK and Ireland with our own dedicated surgical sales team.
We are very excited to sign this deal with Acelity; as it marks the first stage in our substantial growth plans for the next three to five years, and for Acelity it will see its products receive continued regionally focused sales, marketing, logistics and customer service support across German, Austrian and Luxembourg healthcare markets.
This agreement will see us create a new regional head office in or around Wiesbaden where Acelity are currently based with plans to build a 14 strong sales force across Germany and Austria with sales management, local customer services and a marketing support team all overseen by a sales and marketing director.